Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02726204 · ClinicalTrials.gov registry record · NA
Evaluation of a Wearable Exoskeleton for Functional Arm Training
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 28
- Enrollment target
NCT02726204: Completed NA study, sponsored by NYU Langone Health.
NCT02726204 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 28 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02726204, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate how the cable-driven arm exoskeleton (CAREX) can assist task performance during 3D arm movement tasks under various experimental conditions in healthy individuals and patients with stroke. This study is designed to test motor learning with the robotic rehabilitative device CAREX under three conditions in healthy subjects and subjects with post-stroke hemiparesis.
Interventions
- OTHER Gravity Elimination Alone
- OTHER Path Assistance Alone
- OTHER Path Assistance and Gravity Elimination
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2015-06-01 |
| Est. Completion | 2016-05-05 |
| Phase | NA |
What the finished NCT02726204 record still lists
NCT02726204 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 3 interventions - of which Gravity Elimination Alone is the first listed.
NCT02726204 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02726204 about?
NCT02726204 is a clinical study titled "Evaluation of a Wearable Exoskeleton for Functional Arm Training". The purpose of this study is to investigate how the cable-driven arm exoskeleton (CAREX) can assist task performance during 3D arm movement tasks under various experimental conditions in healthy individuals and patients with stroke. This study is designed to test motor learning with the robotic reha...
What is the current status of trial NCT02726204?
This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2015-06-01. Estimated completion is 2016-05-05.
What interventions are being tested in trial NCT02726204?
The interventions under investigation include: Gravity Elimination Alone (OTHER), Path Assistance Alone (OTHER), Path Assistance and Gravity Elimination (OTHER).
Who is sponsoring clinical trial NCT02726204?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02726204's enrollment target sits among peer trials
28 1704th of 2000 higher than 293 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI